Smoking Linked to Early Vision Loss & Cataracts

Translate to Spanish or other 102 languages!

Smoking increases your risk of developing serious eye conditions and permanent sight loss. Image for illustration purposes
Smoking increases your risk of developing serious eye conditions and permanent sight loss. Image for illustration purposes

Mega Doctor News

- Advertisement -

WORLD HEALTH ORGANIZATTION – A new brief finds that smokers stand to develop age-related macular degeneration up to 5.5 years earlier than non-smokers. This blurs a person’s central vision making it difficult for them to do everyday tasks like reading or driving. The brief was developed by WHO, together with the International Agency for the Prevention of Blindness and the University of Newcastle.

People who live with tobacco users are twice as likely to develop age-related macular degeneration from second-hand smoke.

“Smoking increases your risk of developing serious eye conditions and permanent sight loss. Quitting smoking and having regular eye tests can help improve eye health and prevent avoidable sight loss”, said Jude Stern, Head of Knowledge Management, from the International Agency for the Prevention of Blindness.

- Advertisement -

The brief also highlights that tobacco use increases the risk of developing cataracts. Once cataracts develop, the only way to restore vision is surgical removal and replacement of the cloudy lens. Around 94 million people globally have moderate or severe distance vision impairment or blindness due to unaddressed cataract [1].

E-cigarette flavors may increase the production of free radicals*, which damage DNA, which can lead to cataracts. The use of e-cigarettes may reduce blood flow to the eyes, alter retinal function and lead to an increased risk of developing eye cancer.

“WHO urges everyone not to use tobacco and e-cigarettes to protect their overall health, including eye health,” said Vinayak Prasad, Head of the No Tobacco Unit at the World Health Organization.


Reference

- Advertisement -

[1] GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7.

*Definition: free radicals are unstable atoms that can build up in cells and cause damage to other molecules, such as DNA, lipids, and proteins. This damage may increase the risk of cancer and other diseases. NCI Dictionary of Cancer Terms, U.S. National Cancer Institute, 2021

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -